Encelion LLC v. Mobvoi, Inc. — Voluntarily Dismissed Without Prejudice
Encelion LLC brought a patent infringement action against wearable tech company Mobvoi, Inc. in the Eastern District of Texas, asserting US11471072B2 covering pulse sensor systems and methods. The case closed after 224 days when Encelion voluntarily dismissed all claims without prejudice, with each party bearing its own costs.
Pulse sensor patent suit against Mobvoi ends without a merits ruling
On November 6, 2025, Encelion LLC filed suit against Mobvoi, Inc. in the United States District Court for the Eastern District of Texas (Case No. 2:25-cv-01106), asserting infringement of US11471072B2 — a patent directed to a pulse sensor, system, and method for using a pulse sensor. Mobvoi, Inc. is a technology company operating in the wearable device space, making it a commercially relevant target for a pulse-sensing patent assertion.
The recorded Basis of Termination is Voluntary Dismissal. The docket order states that Encelion filed a Notice of Dismissal representing that the case is voluntarily dismissed WITHOUT PREJUDICE, which the court accepted and acknowledged pursuant to Rule 41(a)(1)(A)(i), dismissing all pending claims and causes of action without prejudice and denying all other pending requests for relief as moot. Each party was ordered to bear its own costs, expenses, and attorneys' fees.
The case resolved in approximately 224 days without any defendant answer or appearance on the docket. A Rule 41(a)(1)(A)(i) dismissal is available only before the defendant has served an answer or motion for summary judgment, suggesting the case closed at an early procedural stage. Because the dismissal is without prejudice, the specific terms — if any — underlying Encelion's decision to withdraw are not disclosed in the available public record.
See Complete Case & Patent Analysis →Filing to Voluntary dismissal in 224 days
224 days from filing to voluntary dismissal in E.D. Texas
US11471072B2 — Pulse Sensor, System, and Method
Any company developing, manufacturing, or commercialising products that incorporate pulse sensing — including smartwatches, fitness bands, medical wearables, and health-monitoring platforms — should assess their exposure to US11471072B2. This patent has been actively asserted in litigation and has not been invalidated or limited by any court ruling. The without-prejudice dismissal means the patent holder retains full enforcement rights.
Official order — verbatim text
The court's order accepts Encelion's unilateral Rule 41(a)(1)(A)(i) notice, confirming that no defendant answer or dispositive motion had been filed. The explicit 'without prejudice' designation preserves Encelion's right to refile, and the cost-neutrality order means neither party extracted a financial concession through the dismissal itself. No substantive ruling on US11471072B2 was made.
Voluntarily dismissed: what the Rule 41 dismissal means for both parties
Rule 41(a)(1)(A)(i): plaintiff exits before defendant responds
A Rule 41(a)(1)(A)(i) voluntary dismissal is available as of right before the defendant serves an answer or motion for summary judgment. No court approval is required, and the court here accepted and acknowledged the notice. The dismissal without prejudice means the litigation itself ends, but no merits determination was made on validity or infringement of US11471072B2.
No merits adjudicationWithout prejudice: refiling remains legally available
A dismissal without prejudice does not bar Encelion from bringing future claims on the same patent against Mobvoi or other parties, subject to applicable statutes of limitations. Whether this dismissal reflects a private resolution, a strategic retreat, or a change in litigation posture is not disclosed in the available public record. The public docket is silent on any underlying terms.
Refiling not barredMobvoi avoids a merits ruling — but patent risk persists
Mobvoi, Inc. obtained a dismissal of all claims without any finding of infringement or non-infringement, and without any ruling on patent validity. No defendant law firm or agent appeared on the public docket. While Mobvoi bears no adverse judgment, the without-prejudice nature of the dismissal means the asserted patent remains enforceable and future assertion risk cannot be ruled out.
No adverse findingPulse sensor IP remains unresolved for the wearables sector
US11471072B2 has not been tested on its merits before any court. Companies developing or commercialising pulse sensor technologies — particularly in wearables — should note that this patent remains active and enforceable. The cost-neutrality order and early-stage dismissal do not provide any market signal about the patent's validity or claim scope. Freedom-to-operate analysis remains advisable for players in this space.
Patent still enforceableFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Encelion LLC | Company | /Search in Eureka ↗ |
| Defendant | Mobvoi, Inc. | Company | /Search in Eureka ↗ |
| Plaintiff counsel | Isaac Phillip Rabicoff | Attorney | Counsel for Encelion LLCSearch in Eureka ↗ |
| Plaintiff law firm | Rabicoff Law LLC | Law Firm | Representing Encelion LLCSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
R&D signals in pulse sensor and wearable biometric technology
Forward-looking patent and innovation intelligence surfaced from the Encelion v. Mobvoi assertion — relevant to R&D teams in wearable health and biometric sensing.
Encelion's pulse sensor IP: how broad is the portfolio?
US11471072B2 is the only patent asserted in this action, but understanding Encelion LLC's broader filing activity — including continuation applications, related family members, and co-pending applications under US17/206065 — is essential for assessing the full scope of exposure in pulse sensing. Portfolio mapping can reveal whether additional claims are pending that may cover adjacent implementations.
Portfolio mappingFiling trends in pulse and photoplethysmography sensing
Pulse sensing — particularly optical photoplethysmography (PPG) used in wearables — has attracted significant patent filing activity from consumer electronics and medical device companies. Tracking filing trends in this domain can help R&D teams identify crowded claim spaces, assess the density of granted rights, and locate white-space opportunities for differentiated innovation.
Filing trend analysisMobvoi's biometric sensing patent position
Mobvoi, Inc. operates in the smartwatch and wearable AI assistant space. Assessing Mobvoi's own patent portfolio in pulse and biometric sensing — including any defensive filings or cross-licensing positions — provides context for how the company is positioned to respond to future assertions and whether it holds leverage in the wearable health-monitoring IP landscape.
Defensive IP auditAdjacent innovation opportunities near US11471072B2
With pulse sensor systems and methods an active area of assertion, R&D teams should look for design-around opportunities and unprotected adjacent spaces — such as multi-sensor fusion, context-adaptive sampling algorithms, or AI-driven signal correction — where novel filings could establish defensive or offensive IP positions without overlapping with the asserted claims of US11471072B2.
Design-around opportunitySimilar patent cases: pulse sensor and wearable health-monitoring IP in E.D. Texas
Explore related patent infringement actions involving biometric sensing and wearable technology patents filed in the Eastern District of Texas and comparable venues.
What this case signals for the pulse sensor and wearables IP landscape
An early voluntary dismissal without prejudice in E.D. Texas leaves patent risk unresolved — and the wearables sector exposed.
E.D. Texas remains a preferred venue for early-stage patent assertions
Encelion's choice of the Eastern District of Texas for a pulse sensor assertion is consistent with its reputation as a plaintiff-friendly forum. The case's early termination before any defendant response suggests strategic flexibility was preserved — whether for negotiation, refiling, or redirection of enforcement efforts.
US11471072B2 is untested — wearables companies face residual infringement risk
No court has ruled on the validity, scope, or infringement of US11471072B2. Wearable device manufacturers and pulse sensor technology companies should treat this patent as an active enforcement risk. A proactive FTO assessment and claim mapping against pulse sensor implementations is advisable before product launch or market expansion.
Encelion v Mobvoi — key questions answered
The case was voluntarily dismissed without prejudice by Encelion LLC under Rule 41(a)(1)(A)(i). The court accepted and acknowledged the notice, dismissed all pending claims, and ordered each party to bear its own costs, expenses, and attorneys' fees. No merits ruling was made on US11471072B2.
A without-prejudice dismissal does not bar Encelion from bringing future infringement claims on US11471072B2 against Mobvoi or other parties, subject to applicable statutes of limitations. The specific reasons for the dismissal are not disclosed in the available public record.
The asserted patent is US11471072B2, filed under application number US17/206065. It covers a pulse sensor, system, and method for using a pulse sensor — technology directly relevant to wearable health and fitness monitoring devices.
No. The case was dismissed without prejudice at an early stage before any defendant answer or dispositive motion was filed. No claim construction, validity ruling, or infringement determination was made. US11471072B2 remains an active, enforceable patent with its scope untested by any court.
Encelion LLC was represented by Isaac Phillip Rabicoff of Rabicoff Law LLC. No defendant counsel or law firm appears in the available public docket record for Mobvoi, Inc., consistent with the case closing before any defendant response was filed.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.